Lobbying

Centrient Pharmaceuticals's latest lobbying report covers Q2 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $140K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Manufacturing.

Centrient Pharmaceuticals

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$140K
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Centrient Pharmaceuticals lobbying by quarter
Centrient Pharmaceuticals lobbying by quarter
QuarterAmountReports
Q4 2022$140K1
Q1 2023$70K1
Q2 2023$30K1
Q3 2023$30K1
Q4 2023$30K1
Q1 2024$30K1
Q2 2024$30K1
Q3 2024$30K1
Q4 2024$10K1
Q1 2025$50K1
Q2 2025$20K1
Q3 2025$80K1
Q4 2025$80K1
Q1 2026$60K1
Q2 2026$01
Q3 2026$00

By issue

  • Health issues$187.8K · 14 reports
  • Manufacturing$187.8K · 14 reports
  • Pharmacy$187.8K · 14 reports
  • Defense$62.8K · 7 reports
  • Budget and appropriations$35.3K · 3 reports
  • Trade$28.3K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • SENATE14 reports
  • HOUSE OF REPRESENTATIVES12 reports
  • Health & Human Services, Dept of (HHS)11 reports
  • Natl Economic Council (NEC)10 reports
  • Office of Management & Budget (OMB)5 reports
  • Commerce, Dept of (DOC)4 reports
  • Natl Security Council (NSC)4 reports
  • White House Office4 reports
  • Office of Science & Technology Policy (OSTP)3 reports
  • Food & Drug Administration (FDA)2 reports

Firms it paid

Firm
Akin Gump Strauss Hauer & Feld$690K15 quarters

Former officials lobbying for it

Former position
SAM OLSWANGERLeg staff, Rep Webster, Jan 11-Jun 11; intrn, Rep Blackburn, Sep 08-Dec 08Q3 2025
CASEY CHRISTINE HIGGINSAsst to Spkr for Policy and Trade Cnsl, Paul Ryan, Nov 15-Jan 19; Trade Cncl to House Ways & Means, Jan 15-Nov 15; LC to Rep. Paul Ryan, Oct 11-Jan 15; Law Clrk House Budget Comm, Sep 09-May 10.Q1 2023
ED PAGANOAdvsr, Sen Harkin, 2014; Dep Asst to the President for Leg Affairs and Sen Liaison, Exec Ofc of the President, 2012-14; CoS, Sen Leahy, 2005-11; Sr Cnsl, Sen Judiciary Comm, 1997-04Q4 2022

Lobbying reports

Filed by
07/20for Q2Akin Gump Strauss Hauer & FeldUnder $5,000
04/20for Q1Akin Gump Strauss Hauer & Feld$60K
01/20for Q4 2025Akin Gump Strauss Hauer & Feld$80K
25/10/20for Q3 2025Akin Gump Strauss Hauer & Feld$80K
25/07/21for Q2 2025Akin Gump Strauss Hauer & Feld$20K
25/04/21for Q1 2025Akin Gump Strauss Hauer & Feld$50K
25/01/21for Q4 2024Akin Gump Strauss Hauer & Feld$10K
24/10/18for Q3 2024Akin Gump Strauss Hauer & Feld$30K
24/07/19for Q2 2024Akin Gump Strauss Hauer & Feld$30K
24/04/19for Q1 2024Akin Gump Strauss Hauer & Feld$30K
24/01/19for Q4 2023Akin Gump Strauss Hauer & Feld$30K
23/10/20for Q3 2023Akin Gump Strauss Hauer & Feld$30K
23/07/20for Q2 2023Akin Gump Strauss Hauer & Feld$30K
23/04/20for Q1 2023Akin Gump Strauss Hauer & Feld$70K
23/03/24for Q4 2022Akin Gump Strauss Hauer & Feld$140K
23/01/20for Q4 2022Akin Gump Strauss Hauer & Feld$140K